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Background: Left ventricular (LV) systolic dysfunction portends worse outcomes in patients undergoing surgical aortic valve replacement 
(SAVR). The relationship between LV systolic dysfunction and outcomes in transcstheter aortic valve replacement (TAVR) is unclear. 
methods: A retrospective comparison was performed of 586 consecutive patients in a single academic institution undergoing SAVR 
(n=381) or TAVR (n=205) from 1/2002 to 4/2014. Patients with LV systolic dysfunction were classified into LV ejection fraction (LVEF) 
≤ 40% and LVEF ≤ 25% groups. A propensity score was estimated for each patient based on 16 baseline characteristics and a Cox 
proportional hazards model was performed with the propensity score adjustment.
results: TAVR patients in the LVEF ≤ 40% and LVEF ≤ 25% groups were older (p<0.01), had more redo operations (p<0.01), and a higher 
Society of Thoracic Surgeons Predicted Risk of Mortality Score (p<0.01) than SAVR patients. After propensity score adjustment, there were 
no differences in 30-day or mid-term mortality between SAVR and TAVR in the LVEF ≤ 40% group or the LVEF ≤ 25% group (Figure 1). 
TAVR patients in both cohorts had shorter intensive care unit stay (p<0.0001), and overall postoperative (p<0.0001) hospital stay. 
conclusion:  SAVR portends similar in-hospital and mid-term mortality when compared to TAVR in patients with moderate and severe LV 
dysfunction. Assessment by the heart team regarding the most appropriate therapy in these complex patients is necessary.
